Vertex Pharmaceuticals (VRTX) Sale and Maturity of Investments (2009 - 2026)
Vertex Pharmaceuticals (VRTX) recorded Sale and Maturity of Investments - Total of $4.16 billion in Q3 2026, up 212.8% from $1.33 billion a year earlier and up 77.0% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Sale and Maturity of Investments (2009 - 2026) Analysis & Trends
On a TTM basis, Vertex Pharmaceuticals' Sale and Maturity of Investments - Total came in at $9.81 billion as of Sep 30, 2026, up 56.5% year-over-year; for FY2025, it came in at $5.91 billion, up 32.4% from FY2024.
- Annual Sale and Maturity of Investments - Total has increased for three straight years, with a five-year compound annual growth rate of 38.0% (FY2020 to FY2025).
- Across earlier years, Sale and Maturity of Investments - Total came in at $4.47 billion in FY2024 (+378.0%), $934.2 million in FY2023 (+1.5%), $920 million in FY2022 (-7.9%) and $998.6 million in FY2021 (-15.5%).
- The Q3 2026 figure is the highest quarterly Sale and Maturity of Investments - Total in data going back to Q1 2009.
- On a year-over-year basis, Sale and Maturity of Investments - Total has increased for three consecutive quarters, with growth averaging 128.1% over the last eight quarters.
- Peak year-over-year performance for Sale and Maturity of Investments - Total in the last five years was growth of 925.6% in Q4 2022, against a decline of 90.1% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.35 billion (Q2 2026), $2.21 billion (Q1 2026) and $1.09 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 308.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 405.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 88.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | - |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 2.53 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 4.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.16 Bn |
| Jun 30, 2026 | 2.35 Bn |
| Mar 31, 2026 | 2.21 Bn |
| Dec 31, 2025 | 1.09 Bn |
| Sep 30, 2025 | 1.33 Bn |
| Jun 30, 2025 | 1.84 Bn |
| Mar 31, 2025 | 1.64 Bn |
| Dec 31, 2024 | 1.46 Bn |
| Sep 30, 2024 | 1.11 Bn |
| Jun 30, 2024 | 1.18 Bn |
| Mar 31, 2024 | 710.50 Mn |
| Dec 31, 2023 | 218.10 Mn |
| Sep 30, 2023 | 331.20 Mn |
| Jun 30, 2023 | 479.60 Mn |
| Mar 31, 2023 | 100.00 Mn |
| Dec 31, 2022 | 484.10 Mn |
| Sep 30, 2022 | 193.60 Mn |
| Jun 30, 2022 | 112.60 Mn |
| Mar 31, 2022 | 129.70 Mn |
| Dec 31, 2021 | 47.20 Mn |
API Access
Vertex Pharmaceuticals Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();